ImmuCell Corp (ICCC)
5.04
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 12:56
ImmuCell Shares Outstanding: 7.751M for March 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 08, 2024 | 7.751M |
December 31, 2023 | 7.751M |
November 01, 2023 | 7.751M |
September 30, 2023 | 7.747M |
August 04, 2023 | 7.747M |
June 30, 2023 | 7.747M |
May 03, 2023 | 7.747M |
April 14, 2023 | 7.747M |
March 31, 2023 | 7.747M |
March 10, 2023 | 7.747M |
December 31, 2022 | 7.747M |
November 03, 2022 | 7.747M |
September 30, 2022 | 7.747M |
August 02, 2022 | 7.747M |
June 30, 2022 | 7.747M |
May 12, 2022 | 7.743M |
May 06, 2022 | 7.743M |
April 14, 2022 | 7.743M |
March 31, 2022 | 7.743M |
March 18, 2022 | 7.743M |
December 31, 2021 | 7.742M |
October 28, 2021 | 7.742M |
September 30, 2021 | 7.742M |
July 30, 2021 | 7.742M |
June 30, 2021 | 7.742M |
Date | Value |
---|---|
April 30, 2021 | 7.736M |
April 15, 2021 | 7.736M |
April 14, 2021 | 7.736M |
April 13, 2021 | 7.221M |
March 31, 2021 | 7.221M |
March 19, 2021 | 7.221M |
December 31, 2020 | 7.219M |
October 30, 2020 | 7.213M |
September 30, 2020 | 7.213M |
August 04, 2020 | 7.213M |
June 30, 2020 | 7.213M |
May 05, 2020 | 7.213M |
April 14, 2020 | 7.213M |
March 31, 2020 | 7.213M |
March 19, 2020 | 7.213M |
December 31, 2019 | 7.213M |
November 05, 2019 | 7.210M |
September 30, 2019 | 7.210M |
August 01, 2019 | 7.210M |
June 30, 2019 | 7.210M |
May 02, 2019 | 7.210M |
April 17, 2019 | 7.210M |
March 31, 2019 | 7.210M |
March 29, 2019 | 7.210M |
March 26, 2019 | 5.573M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
7.210M
Minimum
May 02 2019
7.751M
Maximum
Nov 01 2023
7.537M
Average
7.742M
Median
Jun 30 2021
Shares Outstanding Benchmarks
NovaBay Pharmaceuticals Inc | 30.10M |
Palatin Technologies Inc | 16.14M |
iBio Inc | 3.484M |
Theriva Biologics Inc | 17.15M |
Oragenics Inc | 4.481M |